Ameriprise’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-67,607
Closed -$478K 4040
2024
Q4
$478K Sell
67,607
-76,531
-53% -$541K ﹤0.01% 3513
2024
Q3
$1.17M Sell
144,138
-167,522
-54% -$1.36M ﹤0.01% 3144
2024
Q2
$1.99M Sell
311,660
-113,495
-27% -$725K ﹤0.01% 2867
2024
Q1
$3.2M Sell
425,155
-19,574
-4% -$147K ﹤0.01% 2633
2023
Q4
$4.12M Sell
444,729
-49,111
-10% -$455K ﹤0.01% 2492
2023
Q3
$5M Buy
493,840
+144,938
+42% +$1.47M ﹤0.01% 2297
2023
Q2
$4.36M Sell
348,902
-7,510
-2% -$93.9K ﹤0.01% 2447
2023
Q1
$4.16M Buy
356,412
+80,173
+29% +$936K ﹤0.01% 2440
2022
Q4
$2.94M Sell
276,239
-25,081
-8% -$267K ﹤0.01% 2620
2022
Q3
$2.92M Buy
301,320
+195,066
+184% +$1.89M ﹤0.01% 2583
2022
Q2
$1.54M Buy
+106,254
New +$1.54M ﹤0.01% 2921
2020
Q3
Sell
-70,314
Closed -$2.05M 3749
2020
Q2
$2.05M Buy
70,314
+38,285
+120% +$1.12M ﹤0.01% 2591
2020
Q1
$837K Buy
32,029
+8,915
+39% +$233K ﹤0.01% 2900
2019
Q4
$802K Buy
23,114
+1,505
+7% +$52.2K ﹤0.01% 3153
2019
Q3
$684K Buy
+21,609
New +$684K ﹤0.01% 3174